Rb and hematopoiesis: Stem cells to anemia

Carl R. Walkley, Vijay G. Sankaran, Stuart H. Orkin

Research output: Contribution to journalReview ArticleResearchpeer-review

18 Citations (Scopus)

Abstract

The retinoblastoma protein, Rb, was one of the first tumor suppressor genes identified as a result of the familial syndrome retinoblastoma. In the period since its identification and cloning a large number of studies have described its role in various cellular processes. The application of conditional somatic mutation with lineage and temporally controlled gene deletion strategies, thus circumventing the lethality associated with germ-line deletion of Rb, have allowed for a reanalysis of the in vivo role of Rb. In the hematopoietic system, such approaches have led to new insights into stem cell biology and the role of the microenvironment in regulating hematopoietic stem cell fate. They have also clarified the role that Rb plays during erythropoiesis and defined a novel mechanism linking mitochondrial function to terminal cell cycle withdrawal. These studies have shed light on the in vivo role of Rb in the regulation of hematopoiesis and also prompt further analysis of the role that Rb plays in both the regulation of hematopoietic stem cells and the terminal differentiation of their progeny.

Original languageEnglish
Article number13
Number of pages9
JournalCell Division
Volume3
DOIs
Publication statusPublished - 8 Sept 2008
Externally publishedYes

Cite this